October 12, 2022
RFA-NS-22-021 - HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to extend RFA-NS-22-021 "HEAL Initiative: Human Pain-associated Genes & Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)" by one council round. The new, resubmission, and revision application due date is March 9, 2023. The new expiration date is March 10, 2023. Changes to the Funding Opportunity Announcement (FOA) are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates:
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| March 17, 2022 | March 17, 2022 |
Not Applicable | July 2022 | October 2022 |
December 2022 |
| October 11, 2022 | October 11, 2022 | Not Applicable | March 2023 | May 2023 |
July 2023 |
Expiration Date: October 12, 2022
Modified to Read:
Part 1. Overview Information
Key Dates:
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| March 17, 2022 | March 17, 2022 |
Not Applicable | July 2022 | October 2022 |
December 2022 |
| October 11, 2022 | October 11, 2022 | Not Applicable | March 2023 | May 2023 |
July 2023 |
| March 9, 2023 | March 9, 2023 | Not Applicable | July 2023 | October 2023 | December 2023 |
Expiration Date: March 10, 2023
All other aspects of this FOA remain unchanged.
Julia L. Bachman, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-827-7383
Email: [email protected]
and Human Services (HHS)
